Physician profile
April Cass
NPI 1710450333
$620.69
in general payments reported to CMS, 2019-2025
17 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.10 · 2022: $101 · 2023: $145 · 2024: $202 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $498.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $94.72 | 2021-2024 | |
| Amgen INC. | $80.08 | 2022-2024 | Repatha, Otezla |
| Pfizer INC. | $75.60 | 2023-2025 | |
| Lilly USA, LLC | $63.73 | 2022-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $52.74 | 2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.06 | 2022-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $32.44 | 2023 | Eliquis |
| Biohaven Pharmaceutical Holding Company LTD. | $27.02 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.94 | 2024 | |
| Dexcom, INC. | $23.09 | 2024 | Dexcom G6 Transmitter |
| Axsome Therapeutics, INC. | $19.94 | 2025 | Symbravo |
| Exact Sciences Corporation | $18.30 | 2024 | Cologuard Collection Kit |
| Medtronic, INC. | $16.31 | 2025 | Inceptiv |
| Merck Sharp & Dohme LLC | $16.14 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.88 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $13.38 | 2024 | Gvoke Hypopen |
| Glaxosmithkline, LLC. | $13.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Cass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.